MTD — Mettler-Toledo International Inc. stock price and chart

MTD

Mettler-Toledo International Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.04% · Russell 1000 0.04% · US Stock Market 0.04% · Russell 3000 0.04% · MSCI World 0.03% · MSCI ACWI 0.03%

$1,293.52+1.01%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

Volume

20162019202120242026

400.0600.0800.01000.01200.01400.01600.001.0M2.0M$1293.52

2026-09-11

Price$1293.52

MA20$1273.07

MA50$1308.65

Vol895.9K

What would $1,000 invested in MTD be worth today? →

MTD returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $1,293.52
Change YTD: -7.22%
Next earnings: Nov 5, 2026
Market cap: 25.9B2016-09 11B2026-09 25.9B+135.3% over the window
Enterprise value: 28.1B
Shares outstanding: 20M2016-06 26.5M2026-06 20M-24.4% over the window
52W low: $1,023.05
52W high: $1,525.17
From 52W high: -15.19%
From 52W low: +26.44%
52W range: 54%
Beta: 1.22

Volume

Rel volume: 0.55×
30D volume: 170.7K
30D $ vol: 237.8M

Fundamentals

Sales (ttm): 4.1B2016-06 2.4B2026-06 4.1B+70.4% over the window
Sales/share: $206.322016-06 $91.572026-06 $206.32+125.3% over the window
EPS (ttm): $44.442016-06 $12.932026-06 $44.44+243.7% over the window
FCF (ttm): 864M2016-06 362.9M2026-06 864M+138.0% over the window
FCF/share: $43.122016-06 $13.702026-06 $43.12+214.7% over the window
Book value/share: $0.642016-06 $18.572026-06 $0.64-96.6% over the window
Net margin: 21.91%2016-06 14.7%2026-06 21.9%+48.7% over the window
ROE: 7062.40%2016-06 72.7%2026-06 7062.4%+9619.4% over the window
ROA: 24.67%2016-06 17.3%2026-06 24.7%+42.3% over the window
Debt / equity: 159.45×2016-06 1.412026-06 159.45+11215.3% over the window
Current ratio: 1.122016-06 1.522026-06 1.12-26.3% over the window

Growth (CAGR, ttm) · 10Y

Sales: +6.92%2025-06-30 → 2026-06-303.9B → 4.1B (+6.9% total)+1.53%2022-12-31 → 2026-06-303.9B → 4.1B (+5.5% total)+3.54%2021-06-30 → 2026-06-303.5B → 4.1B (+19.0% total)+5.48%2016-06-30 → 2026-06-302.4B → 4.1B (+70.4% total)
Net income: +9.15%2025-06-30 → 2026-06-30829.8M → 905.6M (+9.1% total)+1.07%2022-12-31 → 2026-06-30872.5M → 905.6M (+3.8% total)+7.00%2021-06-30 → 2026-06-30645.9M → 905.6M (+40.2% total)+9.74%2016-06-30 → 2026-06-30357.5M → 905.6M (+153.3% total)
FCF: +1.90%2025-06-30 → 2026-06-30847.8M → 864M (+1.9% total)+0.22%2023-06-30 → 2026-06-30858.4M → 864M (+0.7% total)+2.13%2021-06-30 → 2026-06-30777.6M → 864M (+11.1% total)+9.06%2016-06-30 → 2026-06-30362.9M → 864M (+138.0% total)
Shares: -2.73%2025-06-30 → 2026-06-3020.6M → 20M (-2.7% total)-2.87%2023-06-30 → 2026-06-3021.9M → 20M (-8.4% total)-2.82%2021-06-30 → 2026-06-3023.1M → 20M (-13.3% total)-2.75%2016-06-30 → 2026-06-3026.5M → 20M (-24.4% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +12.50%2025-06-30 → 2026-06-30$39.50 → $44.44 (+12.5% total)+4.26%2022-12-31 → 2026-06-30$38.41 → $44.44 (+15.7% total)+8.26%2021-06-30 → 2026-06-30$29.88 → $44.44 (+48.7% total)+13.14%2016-06-30 → 2026-06-30$12.93 → $44.44 (+243.7% total)
Sales/share: +9.92%2025-06-30 → 2026-06-30$187.71 → $206.32 (+9.9% total)+4.43%2022-12-31 → 2026-06-30$177.31 → $206.32 (+16.4% total)+6.54%2021-06-30 → 2026-06-30$150.28 → $206.32 (+37.3% total)+8.46%2016-06-30 → 2026-06-30$91.57 → $206.32 (+125.3% total)
FCF/share: +4.77%2025-06-30 → 2026-06-30$41.16 → $43.12 (+4.8% total)+3.18%2023-06-30 → 2026-06-30$39.26 → $43.12 (+9.8% total)+5.09%2021-06-30 → 2026-06-30$33.64 → $43.12 (+28.2% total)+12.15%2016-06-30 → 2026-06-30$13.70 → $43.12 (+214.7% total)
Book value/share: n/an/a-40.08%2021-06-30 → 2026-06-30$8.28 → $0.64 (-92.3% total)-28.60%2016-06-30 → 2026-06-30$18.57 → $0.64 (-96.6% total)
Price: +0.84%2025-09-11 → 2026-09-11$1,282.72 → $1,293.52 (+0.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+4.64%2023-09-11 → 2026-09-11$1,128.99 → $1,293.52 (+14.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-4.09%2021-09-10 → 2026-09-11$1,593.99 → $1,293.52 (-18.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+12.77%2016-09-09 → 2026-09-11$388.80 → $1,293.52 (+232.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +0.84%2025-09-11 → 2026-09-11$1,282.72 → $1,293.52 (+0.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+4.64%2023-09-11 → 2026-09-11$1,128.99 → $1,293.52 (+14.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-4.09%2021-09-10 → 2026-09-11$1,593.99 → $1,293.52 (-18.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+12.77%2016-09-09 → 2026-09-11$388.80 → $1,293.52 (+232.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 29.1×2016-09 29.772026-09 28.61-3.9% over the window
Fwd P/E: 26.0×
P/S (ttm)Market cap ÷ TTM revenue.: 6.3×2016-09 4.462026-09 6.27+40.7% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2021.2×2016-09 22.012026-09 2020.82+9083.0% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 30.0×2016-09 28.962026-09 29.99+3.6% over the window
EV/EBITDA (fy): 22.5×
EV/Sales (ttm): 6.8×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 3.33%2016-06 3.3%2026-06 3.4%+2.4% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 20.0M ÷ 20.6M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 2.73%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (2.73%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($24.2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 2.73%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($775M) ÷ today's market cap ($25.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 2.99%2016-06 4.5%2026-06 3.0%-33.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $775M + TTM dividends $0) ÷ today's market cap ($25.9B). Same caveat as the cash buyback yield.: 2.99%2016-06 4.5%2026-06 3.0%-33.0% over the window

Vs own 10Y history

P/E: 10th
P/S: 42nd
P/B: 90th
P/FCF: 17th

Bar = where today’s multiple sits in MTD’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

+1.01%

-4.62%

-10.08%

+13.34%

YTD

-7.22%

+3.24%

-17.57%

Financial statements

Open full MTD financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

Mettler-Toledo International Inc. (MTD) trades at $1,293.52 with a live price and an interactive chart covering 28+ years of daily price history, plus key valuation metrics. ChartRow also publishes MTD’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full MTD financial statements →

MTD — Mettler-Toledo International Inc. price, chart and key statistics

Key stats

Price data

Volume

Fundamentals

Growth (CAGR, ttm) · 10Y

Per-share growth (CAGR, ttm) · 10Y

Valuation

Vs own 10Y history

Performance · price return · windows as of 2026-09-11

Financial statements

Related Healthcare